Patient Guide: Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 24 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03734198
Status: ACTIVE_NOT_RECRUITING
Condition: Relapsed or Refractory Chronic Lymphocytic Leukemia
Phase: PHASE2

Find a Study Location Near You

This study is available at 24 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Amiens,
  • Annecy,
  • Besançon,
  • • And 21 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily